| protein lipid complex subunit organization | GO:0071825 | 12 | 1.000 | Human Mouse |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 1.000 | Human Mouse |
| lipoprotein metabolic process | GO:0042157 | 43 | 1.000 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.999 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.997 | Human Mouse |
| sterol metabolic process | GO:0016125 | 58 | 0.997 | |
| cholesterol transport | GO:0030301 | 38 | 0.991 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.986 | Mouse |
| cholesterol homeostasis | GO:0042632 | 44 | 0.984 | Human Mouse |
| alcohol metabolic process | GO:0006066 | 116 | 0.982 | |
| steroid metabolic process | GO:0008202 | 119 | 0.979 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.976 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.973 | Mouse |
| low density lipoprotein particle remodeling | GO:0034374 | 2 | 0.967 | Mouse |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.960 | Mouse |
| sterol homeostasis | GO:0055092 | 45 | 0.945 | Human Mouse |
| cholesterol efflux | GO:0033344 | 24 | 0.943 | |
| protein lipid complex remodeling | GO:0034368 | 6 | 0.943 | Human Mouse |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.921 | |
| lipid catabolic process | GO:0016042 | 69 | 0.916 | Mouse |
| lipid homeostasis | GO:0055088 | 63 | 0.908 | Human Mouse |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.898 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.897 | |
| lipid transport | GO:0006869 | 98 | 0.894 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.890 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.872 | |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.866 | Human Mouse |
| cholesterol esterification | GO:0034435 | 3 | 0.860 | Human Mouse |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.846 | Mouse |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 4 | 0.842 | |
| triglyceride rich lipoprotein particle remodeling | GO:0034370 | 2 | 0.841 | Human Mouse |
| triglyceride catabolic process | GO:0019433 | 9 | 0.835 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.804 | |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.784 | Human Mouse |
| negative regulation of fibrinolysis | GO:0051918 | 1 | 0.776 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.771 | |
| intestinal absorption | GO:0050892 | 13 | 0.770 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.768 | |
| sterol transport | GO:0015918 | 38 | 0.758 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.754 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.739 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.724 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.721 | |
| regulation of fibrinolysis | GO:0051917 | 1 | 0.717 | |
| fibrinolysis | GO:0042730 | 3 | 0.701 | |
| regulation of cholesterol biosynthetic process | GO:0045540 | 8 | 0.693 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.688 | Mouse |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.686 | |
| sterol biosynthetic process | GO:0016126 | 17 | 0.676 | |
| positive regulation of cholesterol storage | GO:0010886 | 3 | 0.649 | |
| negative regulation of hemostasis | GO:1900047 | 11 | 0.647 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.638 | |
| negative regulation of coagulation | GO:0050819 | 11 | 0.630 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.618 | Human Mouse |
| hemostasis | GO:0007599 | 78 | 0.611 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.608 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.601 | Human Mouse |
| lipid localization | GO:0010876 | 126 | 0.595 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.570 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.565 | Human Mouse |
| reverse cholesterol transport | GO:0043691 | 6 | 0.563 | Human |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.558 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.557 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.535 | |
| regulation of defense response | GO:0031347 | 233 | 0.535 | Human Mouse |
| regulation of protein processing | GO:0070613 | 96 | 0.529 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.521 | |
| sterol esterification | GO:0034434 | 3 | 0.520 | Human Mouse |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.511 | |
| cholesterol storage | GO:0010878 | 4 | 0.508 | |
| amine metabolic process | GO:0009308 | 45 | 0.503 | Human |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.500 | |
| digestion | GO:0007586 | 40 | 0.497 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.496 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.490 | |
| liver development | GO:0001889 | 66 | 0.482 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.478 | Mouse |
| plasma lipoprotein particle assembly | GO:0034377 | 6 | 0.478 | Human |
| cellular amine metabolic process | GO:0044106 | 44 | 0.472 | Human |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.469 | Mouse |
| coagulation | GO:0050817 | 78 | 0.468 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.448 | |
| cholesterol biosynthetic process | GO:0006695 | 15 | 0.440 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.432 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.428 | |
| cholesterol catabolic process | GO:0006707 | 5 | 0.428 | Mouse |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.424 | |
| wound healing | GO:0042060 | 157 | 0.420 | |
| triglyceride mobilization | GO:0006642 | 5 | 0.410 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.403 | |
| protein processing | GO:0016485 | 163 | 0.401 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.399 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.397 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.389 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.377 | |
| negative regulation of serine type endopeptidase activity | GO:1900004 | 2 | 0.374 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.372 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.367 | |
| high density lipoprotein particle assembly | GO:0034380 | 3 | 0.354 | Human |
| regulation of mapk cascade | GO:0043408 | 248 | 0.354 | |
| regulation of wound healing | GO:0061041 | 40 | 0.351 | |
| spermatogenesis | GO:0007283 | 284 | 0.347 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.345 | |
| sperm motility | GO:0030317 | 47 | 0.344 | |
| lipid digestion | GO:0044241 | 7 | 0.333 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.330 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.323 | |
| regulation of system process | GO:0044057 | 200 | 0.321 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.319 | |
| regulation of coagulation | GO:0050818 | 31 | 0.315 | |
| negative regulation of blood coagulation | GO:0030195 | 11 | 0.308 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.305 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.304 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.301 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.299 | |
| positive regulation of protein kinase c activity | GO:1900020 | 1 | 0.297 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.296 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.292 | |
| regulation of serine type endopeptidase activity | GO:1900003 | 2 | 0.289 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.288 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.287 | Mouse |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.286 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.284 | Human Mouse |
| neutral lipid catabolic process | GO:0046461 | 11 | 0.281 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.279 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.279 | Human Mouse |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.275 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.274 | Human Mouse |
| response to peptide hormone | GO:0043434 | 127 | 0.274 | |
| positive regulation of coagulation | GO:0050820 | 13 | 0.272 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.271 | |
| cellular response to peptide | GO:1901653 | 92 | 0.270 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.267 | |
| hexose metabolic process | GO:0019318 | 98 | 0.259 | |
| ossification | GO:0001503 | 216 | 0.259 | |
| endocrine system development | GO:0035270 | 98 | 0.258 | |
| response to oxygen levels | GO:0070482 | 62 | 0.254 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.253 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.248 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.247 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.240 | Mouse |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.240 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.238 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.236 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.231 | |
| astrocyte activation | GO:0048143 | 2 | 0.229 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.223 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.221 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.218 | |
| response to metal ion | GO:0010038 | 47 | 0.217 | |
| mapk cascade | GO:0000165 | 281 | 0.216 | |
| response to retinoic acid | GO:0032526 | 56 | 0.215 | |
| response to steroid hormone | GO:0048545 | 56 | 0.213 | |
| maintenance of location | GO:0051235 | 89 | 0.213 | |
| lipid modification | GO:0030258 | 65 | 0.211 | Human Mouse |
| very low density lipoprotein particle remodeling | GO:0034372 | 1 | 0.210 | Human Mouse |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.210 | Human Mouse |
| nitrogen compound transport | GO:0071705 | 271 | 0.209 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.208 | Human Mouse |
| macromolecular complex remodeling | GO:0034367 | 6 | 0.206 | Human Mouse |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.205 | |
| blood coagulation | GO:0007596 | 76 | 0.203 | |
| steroid esterification | GO:0034433 | 3 | 0.200 | Human Mouse |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.198 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.198 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.197 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.195 | |
| cofactor transport | GO:0051181 | 4 | 0.192 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.188 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.182 | |
| camera type eye development | GO:0043010 | 266 | 0.181 | |
| hepatocyte growth factor receptor signaling pathway | GO:0048012 | 3 | 0.180 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.179 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.179 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.178 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.178 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.177 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.177 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.176 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.173 | |
| response to peptide | GO:1901652 | 136 | 0.172 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.171 | Human Mouse |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.168 | |
| endothelial cell migration | GO:0043542 | 44 | 0.168 | |
| gland development | GO:0048732 | 330 | 0.168 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.164 | |
| phospholipid homeostasis | GO:0055091 | 6 | 0.163 | Human |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.163 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.160 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.160 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.156 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.155 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.151 | |
| positive regulation of growth | GO:0045927 | 104 | 0.151 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.150 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.148 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.148 | |
| cytokine production | GO:0001816 | 319 | 0.148 | Human |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.145 | Human Mouse |
| negative regulation of defense response | GO:0031348 | 77 | 0.144 | Human Mouse |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.143 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.142 | |
| epithelial cell development | GO:0002064 | 159 | 0.142 | |
| regulation of fatty acid biosynthetic process | GO:0042304 | 12 | 0.140 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.140 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.138 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.138 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.136 | |
| protein maturation | GO:0051604 | 176 | 0.136 | |
| kidney development | GO:0001822 | 213 | 0.135 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.135 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.134 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.133 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.131 | |
| regulation of digestive system process | GO:0044058 | 13 | 0.130 | |
| inflammatory response | GO:0006954 | 244 | 0.130 | Human Mouse |
| astrocyte differentiation | GO:0048708 | 43 | 0.130 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.129 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.128 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.128 | |
| artery development | GO:0060840 | 53 | 0.128 | Mouse |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.127 | |
| male gamete generation | GO:0048232 | 285 | 0.127 | |
| response to inorganic substance | GO:0010035 | 96 | 0.126 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.125 | |
| epithelium migration | GO:0090132 | 63 | 0.124 | |
| trophoblast giant cell differentiation | GO:0060707 | 15 | 0.123 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.121 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.121 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.121 | |
| response to acid chemical | GO:0001101 | 111 | 0.121 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.120 | |
| renal system development | GO:0072001 | 225 | 0.120 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.119 | Human |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.118 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.118 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.117 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.116 | |
| branching involved in salivary gland morphogenesis | GO:0060445 | 26 | 0.116 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.115 | |
| cell adhesion | GO:0007155 | 329 | 0.115 | Human |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.114 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.114 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.114 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.113 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 8 | 0.112 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.111 | Mouse |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.111 | |
| activation of immune response | GO:0002253 | 138 | 0.111 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.111 | Human |
| response to oxidative stress | GO:0006979 | 123 | 0.111 | Mouse |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.110 | |
| circulatory system process | GO:0003013 | 197 | 0.109 | Mouse |
| response to insulin | GO:0032868 | 100 | 0.108 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.106 | |
| gliogenesis | GO:0042063 | 141 | 0.106 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.105 | |
| complement activation | GO:0006956 | 16 | 0.104 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.103 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.103 | |
| triglyceride homeostasis | GO:0070328 | 15 | 0.103 | Human |
| ammonia assimilation cycle | GO:0019676 | 2 | 0.102 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.101 | Human |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.100 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.100 | |
| negative regulation of wound healing | GO:0061045 | 14 | 0.099 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.099 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.097 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.096 | |
| bone development | GO:0060348 | 120 | 0.095 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.095 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.095 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.095 | Mouse |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.094 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.094 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.094 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.093 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.093 | |
| phospholipid transport | GO:0015914 | 21 | 0.093 | Human |
| regulation of cell motility | GO:2000145 | 236 | 0.092 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.091 | Human |
| amide transport | GO:0042886 | 138 | 0.091 | |
| glial cell differentiation | GO:0010001 | 131 | 0.091 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.090 | |
| regulation of ossification | GO:0030278 | 112 | 0.090 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.090 | |
| sterol catabolic process | GO:0016127 | 5 | 0.089 | Mouse |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.088 | Human |
| myosin filament organization | GO:0031033 | 3 | 0.088 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.088 | |
| epithelial cell migration | GO:0010631 | 63 | 0.087 | |
| carbohydrate transport | GO:0008643 | 62 | 0.086 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.086 | |
| respiratory system development | GO:0060541 | 190 | 0.086 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.085 | |
| response to bile acid | GO:1903412 | 1 | 0.085 | |
| muscle system process | GO:0003012 | 141 | 0.085 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.084 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.084 | Human |
| angiogenesis | GO:0001525 | 201 | 0.084 | |
| regulation of lipoprotein metabolic process | GO:0050746 | 4 | 0.083 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.083 | |
| chemotaxis | GO:0006935 | 247 | 0.083 | Human |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.083 | |
| positive regulation of lipid biosynthetic process | GO:0046889 | 18 | 0.082 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.082 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.082 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.080 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.080 | |
| tissue remodeling | GO:0048771 | 102 | 0.078 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.078 | |
| positive regulation of cholesterol homeostasis | GO:2000189 | 2 | 0.077 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.076 | |
| extracellular structure organization | GO:0043062 | 148 | 0.076 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.076 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.075 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.075 | Human |
| connective tissue development | GO:0061448 | 179 | 0.075 | |
| regulation of glutamate metabolic process | GO:2000211 | 1 | 0.074 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.074 | |
| phasic smooth muscle contraction | GO:0014821 | 8 | 0.074 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.074 | |
| nephron development | GO:0072006 | 109 | 0.074 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.073 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.073 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.073 | Human |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.073 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.073 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.072 | Mouse |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.072 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.072 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.072 | |
| fatty acid transmembrane transport | GO:1902001 | 1 | 0.071 | |
| glial cell development | GO:0021782 | 54 | 0.071 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.071 | |
| glucose metabolic process | GO:0006006 | 92 | 0.071 | |
| kidney epithelium development | GO:0072073 | 121 | 0.071 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.070 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.070 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.070 | |
| lipid storage | GO:0019915 | 36 | 0.070 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.069 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.069 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.069 | Mouse |
| macrophage derived foam cell differentiation | GO:0010742 | 6 | 0.069 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.069 | |
| hexose transport | GO:0008645 | 56 | 0.069 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.069 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.068 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.068 | |
| biomineral tissue development | GO:0031214 | 64 | 0.068 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.068 | Human |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.068 | |
| skeletal system development | GO:0001501 | 356 | 0.068 | |
| 9 cis retinoic acid biosynthetic process | GO:0042904 | 5 | 0.067 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.067 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.067 | Mouse |
| fatty acid catabolic process | GO:0009062 | 25 | 0.067 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.067 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.066 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.066 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.065 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.065 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.065 | |
| response to stilbenoid | GO:0035634 | 22 | 0.065 | Mouse |
| protein activation cascade | GO:0072376 | 19 | 0.064 | |
| high density lipoprotein particle remodeling | GO:0034375 | 4 | 0.064 | |
| regulation of alcohol biosynthetic process | GO:1902930 | 16 | 0.064 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.063 | Mouse |
| protein secretion | GO:0009306 | 111 | 0.063 | Human |
| cell maturation | GO:0048469 | 127 | 0.063 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.062 | Human |
| organ or tissue specific immune response | GO:0002251 | 13 | 0.062 | Mouse |
| regulation of steroid biosynthetic process | GO:0050810 | 26 | 0.062 | |
| regulation of protein kinase c activity | GO:1900019 | 1 | 0.062 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.062 | |
| 9 cis retinoic acid metabolic process | GO:0042905 | 5 | 0.062 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.061 | Human |
| regulation of cholesterol storage | GO:0010885 | 4 | 0.061 | |
| renal system process | GO:0003014 | 48 | 0.061 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.061 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.060 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.060 | |
| regulation of urea metabolic process | GO:0034255 | 1 | 0.060 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.060 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.060 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.059 | |
| lung development | GO:0030324 | 164 | 0.058 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.058 | |
| neuronal action potential | GO:0019228 | 54 | 0.058 | |
| collagen fibril organization | GO:0030199 | 32 | 0.058 | |
| regionalization | GO:0003002 | 337 | 0.058 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.057 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.057 | |
| axonogenesis | GO:0007409 | 274 | 0.056 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.056 | |
| negative regulation of growth | GO:0045926 | 99 | 0.055 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.055 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.055 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.055 | |
| excretion | GO:0007588 | 22 | 0.055 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.054 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.054 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.054 | |
| peptide secretion | GO:0002790 | 114 | 0.053 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.053 | |
| regulation of lipid storage | GO:0010883 | 20 | 0.053 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.053 | |
| transmembrane transport | GO:0055085 | 412 | 0.053 | Human |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.053 | |
| adiponectin activated signaling pathway | GO:0033211 | 4 | 0.053 | |
| very long chain fatty acid catabolic process | GO:0042760 | 2 | 0.053 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.053 | |
| smad protein signal transduction | GO:0060395 | 21 | 0.052 | |
| atp metabolic process | GO:0046034 | 75 | 0.052 | |
| peptide transport | GO:0015833 | 133 | 0.052 | |
| regulation of secretion | GO:0051046 | 274 | 0.052 | Human |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.052 | |
| regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902041 | 22 | 0.051 | |
| fat cell differentiation | GO:0045444 | 160 | 0.051 | |
| ovulation cycle | GO:0042698 | 59 | 0.051 | |
| astrocyte development | GO:0014002 | 12 | 0.051 | |
| skin development | GO:0043588 | 220 | 0.051 | |
| ovarian follicle rupture | GO:0001543 | 2 | 0.051 | |
| oxidation reduction process | GO:0055114 | 342 | 0.050 | Human |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.050 | |
| muscle contraction | GO:0006936 | 101 | 0.050 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.050 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.050 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.050 | |
| gluconeogenesis | GO:0006094 | 39 | 0.048 | |
| urogenital system development | GO:0001655 | 261 | 0.048 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.048 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.048 | |
| response to hypoxia | GO:0001666 | 58 | 0.048 | |
| lipid oxidation | GO:0034440 | 29 | 0.047 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.047 | Human |
| nitric oxide mediated signal transduction | GO:0007263 | 4 | 0.047 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.047 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.047 | |
| embryonic placenta development | GO:0001892 | 98 | 0.047 | |
| developmental maturation | GO:0021700 | 193 | 0.046 | |
| atrial cardiac muscle cell differentiation | GO:0055011 | 2 | 0.046 | |
| homotypic cell cell adhesion | GO:0034109 | 28 | 0.046 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.045 | |
| hormone secretion | GO:0046879 | 128 | 0.045 | |
| response to nutrient levels | GO:0031667 | 109 | 0.045 | Mouse |
| hormone metabolic process | GO:0042445 | 86 | 0.045 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.045 | |
| regulation of phospholipid transport | GO:2001138 | 4 | 0.045 | |
| response to drug | GO:0042493 | 75 | 0.045 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.045 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.045 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.044 | |
| regulation of vitamin d biosynthetic process | GO:0060556 | 1 | 0.044 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.044 | |
| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.044 | |
| protein localization to membrane | GO:0072657 | 108 | 0.043 | |
| tissue regeneration | GO:0042246 | 22 | 0.043 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.043 | |
| dendrite development | GO:0016358 | 115 | 0.043 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.043 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.043 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.043 | Human |
| peristalsis | GO:0030432 | 8 | 0.043 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.043 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.042 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.042 | Human |
| positive regulation of cellular carbohydrate metabolic process | GO:0010676 | 29 | 0.042 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.042 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.042 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.042 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.041 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.041 | |
| spermatid development | GO:0007286 | 108 | 0.041 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.041 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.041 | |
| respiratory tube development | GO:0030323 | 167 | 0.041 | |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.041 | |
| positive regulation of peptide hormone secretion | GO:0090277 | 31 | 0.041 | |
| regulation of glutamine family amino acid metabolic process | GO:0000820 | 1 | 0.041 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.041 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.041 | |
| response to chromate | GO:0046687 | 1 | 0.040 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.040 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.040 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.040 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.040 | |
